Laddar populära aktier...
Inify Laboratories - mandatory notification of trade
Inify Laboratories: Key information regarding potential Subsequent Offering
Inify Laboratories announces successful placement of fully guaranteed private placement
Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed subsequent repair issue
Inify Laboratories AB (publ) - Kommuniké från extra bolagsstämma
Inify Laboratories AB (publ) - Bulletin from the extraordinary general meeting
Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of SEK 150 million
Inify Laboratories - notice of Extraordinary General Meeting on December 6, 2024
Inify Laboratories – kallelse till extra bolagsstämma 6 december 2024
Inify Laboratories: Establishment in the United Kingdom and expansion into gastrointestinal diagnostics
Inify Laboratories: Etablering i Storbritannien och expansion inom mag-tarmdiagnostik
INIFY Laboratories: 62% revenue growth and strong international interest
INIFY Laboratories: 62% omsättningstillväxt och starkt internationellt intresse
Inify Laboratories AB (publ) – summary of Annual General Meeting
Inify Laboratories AB (publ) – kommuniké från årsstämma
Inify Laboratories - More diagnoses delivered in the first quarter than in the whole of 2023
Inify Laboratories - Fler diagnoser levererade under första kvartalet än under hela 2023
Inify Laboratories - Årsredovisning 2023
Inify Laboratories – notice of Annual General Meeting on May 14, 2024
Inify Laboratories – kallelse till årsstämma den 14 maj 2024
Inify Laboratories - Annual Report 2023
Förutser en märkbar ökning av kunder, volym och försäljning under 2024
Foresees a noticeable increase of customers, volume, and sales in 2024
Inify Laboratories erhåller ackreditering som medicinskt laboratorium
Inify Laboratories receives accreditation as a medical laboratory
Kontinuerlig diagnostikverksamhet och mycket positiv kundrespons
Continuous diagnostic operation and very positive feedback from customers
Inify Laboratories - Lyckad laboratorielansering under Q2 med leverans av första prostatacancerdiagnoserna
Inify Laboratories - Successful laboratory launch in Q2 with delivery of first prostate cancer diagnosis
Successful launch of Inify Laboratories’ services, with first patient cases diagnosed
Framgångsrik lansering av Inify Laboratories tjänster – första patientfallen har diagnostiserats
Inify Laboratories - Strong market interest and launch on track
Inify Laboratories - Årsredovisning 2022
Inify Laboratories - notice of Annual General Meeting on May 16, 2023
Inify Laboratories - kallelse till årsstämma den 16 maj 2023
Inify Laboratories - Annual Report 2022
From the heart of their brand-new laboratory comes this panel talk with CEO Fredrik Palm and CTO Arto Järvinen of Inify Laboratories.
Inify Laboratories - Ultramodern AI-based digital pathology laboratory completed in record time
INIFY Laboratories - Laboratory and recruitment on track with positive market feedback
Inify Laboratories AB (publ) – Extra bolagsstämma
Inify Laboratories AB (publ) – Extraordinary General Meeting
Inify’s first ultramodern laboratory on track
Kallelse till extra bolagsstämma i Inify Laboratories AB (publ)
Notice to Extraordinary General Meeting in Inify Laboratories AB (publ)
